Published in PLoS One on August 19, 2015
LINC00472 expression is regulated by promoter methylation and associated with disease-free survival in patients with grade 2 breast cancer. Breast Cancer Res Treat (2015) 0.83
Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma. Oncotarget (2016) 0.77
Identification of transcription factors (TFs) and targets involved in the cholangiocarcinoma (CCA) by integrated analysis. Cancer Gene Ther (2016) 0.75
Docking of CDK1 with antibiotic drugs revealed novel therapeutic value in breast ductal cancer in situ. Oncotarget (2017) 0.75
Bioconductor: open software development for computational biology and bioinformatics. Genome Biol (2004) 143.19
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99
The hallmarks of cancer. Cell (2000) 113.05
Cancer statistics, 2009. CA Cancer J Clin (2009) 83.57
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (2000) 64.32
Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med (2004) 41.02
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet (2005) 29.45
Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol (2009) 22.22
Genes that mediate breast cancer metastasis to lung. Nature (2005) 19.85
Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. J Natl Cancer Inst (2006) 14.60
Concordance among gene-expression-based predictors for breast cancer. N Engl J Med (2006) 13.50
The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med (2007) 13.39
The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics (2006) 12.45
Stromal gene expression predicts clinical outcome in breast cancer. Nat Med (2008) 10.68
Gene expression signature of fibroblast serum response predicts human cancer progression: similarities between tumors and wounds. PLoS Biol (2004) 9.38
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts. Breast Cancer Res (2005) 8.73
On the road to cancer: aneuploidy and the mitotic checkpoint. Nat Rev Cancer (2005) 7.53
Identification of a human mitotic checkpoint gene: hsMAD2. Science (1996) 6.37
MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells. Nature (2001) 6.36
Model-based variance-stabilizing transformation for Illumina microarray data. Nucleic Acids Res (2008) 6.15
Gene expression programs in response to hypoxia: cell type specificity and prognostic significance in human cancers. PLoS Med (2006) 6.04
Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control. Nature (2004) 4.41
Clinical application of the 70-gene profile: the MINDACT trial. J Clin Oncol (2008) 4.13
Causes and consequences of aneuploidy in cancer. Nat Rev Genet (2012) 4.08
Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer (2010) 3.95
Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol (2008) 3.89
Breast cancer: origins and evolution. J Clin Invest (2007) 3.31
GOBO: gene expression-based outcome for breast cancer online. PLoS One (2011) 2.81
A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors. Clin Cancer Res (2011) 2.79
A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res (2005) 2.65
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer. Breast Cancer Res (2008) 2.09
Increased expression of mitotic checkpoint genes in breast cancer cells with chromosomal instability. Clin Cancer Res (2006) 2.02
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest (2013) 1.89
The cell cycle and cancer. Proc Natl Acad Sci U S A (1997) 1.72
The kinase activity of the Ser/Thr kinase BUB1 promotes TGF-β signaling. Sci Signal (2015) 1.61
The spindle checkpoint: a quality control mechanism which ensures accurate chromosome segregation. Chromosome Res (2004) 1.60
Genetic and epigenetic inactivation of mitotic checkpoint genes hBUB1 and hBUBR1 and their relationship to survival. Cancer Res (2002) 1.58
Pooling breast cancer datasets has a synergetic effect on classification performance and improves signature stability. BMC Genomics (2008) 1.45
Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. J Cell Biol (2011) 1.35
Overexpression of the mitotic checkpoint genes BUB1, BUBR1, and BUB3 in gastric cancer--association with tumour cell proliferation. J Pathol (2003) 1.16
PTTG1 oncogene promotes tumor malignancy via epithelial to mesenchymal transition and expansion of cancer stem cell population. J Biol Chem (2012) 1.13
In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene (2008) 1.13
Age-specific gene expression signatures for breast tumors and cross-species conserved potential cancer progression markers in young women. PLoS One (2013) 1.07
Expression of Bub1 gene correlates with tumor proliferating activity in human gastric carcinomas. Pathobiology (2001) 1.00
A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766T. Hum Mutat (2003) 0.93
A 41-gene signature derived from breast cancer stem cells as a predictor of survival. J Exp Clin Cancer Res (2014) 0.93
Synthetic genetic array screen identifies PP2A as a therapeutic target in Mad2-overexpressing tumors. Proc Natl Acad Sci U S A (2014) 0.89
The expression of BIRC5 is correlated with loss of specific chromosomal regions in breast carcinomas. Genes Chromosomes Cancer (2008) 0.88
Favorable outcome associated with an IGF-1 ligand signature in breast cancer. Breast Cancer Res Treat (2012) 0.83
An 18-gene signature for vascular invasion is associated with aggressive features and reduced survival in breast cancer. PLoS One (2014) 0.81
Spindle checkpoint protein links Rb pathway to aneuploidy. Nat Cell Biol (2004) 0.79
Paclitaxel is necessary for improved survival in epithelial ovarian cancers with homologous recombination gene mutations. Oncotarget (2016) 0.76
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. PLoS One (2015) 0.76
Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genet Epidemiol (2015) 0.75